[Cardiovascular manifestations in inflammatory rheumatic diseases]

Area of Science:

• Rheumatology
• Cardiovascular Medicine
• Immunology

Context:

• Increased cardiovascular mortality is observed in patients with inflammatory rheumatic diseases.
• The underlying mechanisms contributing to this heightened risk remain largely undetermined.
• Potential links between atherosclerosis and autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus warrant investigation.

Purpose:

• To elucidate the reasons behind the elevated cardiovascular mortality in inflammatory rheumatic diseases.
• To explore the association between atherosclerosis and specific autoimmune diseases.
• To provide a clearer understanding of the cardiovascular risks in rheumatological patients.

Summary:

• This research investigates the connection between inflammatory rheumatic diseases and cardiovascular mortality.
• It examines the potential role of atherosclerosis in conditions like rheumatoid arthritis and systemic lupus erythematosus.
• The study aims to clarify the unclear reasons for increased cardiovascular risk in these patients.

Impact:

• Provides insights into the cardiovascular risks associated with inflammatory rheumatic diseases.
• Highlights the importance of considering atherosclerosis in the management of rheumatoid arthritis and systemic lupus erythematosus.
• Contributes to a better understanding of autoimmune disease comorbidities and their impact on cardiovascular health.